Spots Global Cancer Trial Database for hypopharynx cancer
Every month we try and update this database with for hypopharynx cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer | NCT01066741 | Oropharynx Canc... Hypopharynx Can... | Homeodent® 1.4% Sodium Bic... | 18 Years - 85 Years | Centre Leon Berard | |
Pembrolizumab in Combination With CRT for LA-SCCHN | NCT02586207 | Head and Neck C... Squamous Cell C... Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer Laryngeal Cance... | pembrolizumab (... Cisplatin Radiation | 18 Years - | Sanford Health | |
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC | NCT00158678 | Oral Cancer Oropharynx Canc... Hypopharynx Can... | IMRT 75 Gy Conventional ra... concomitant cis... | 18 Years - | Groupe Oncologie Radiotherapie Tete et Cou | |
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation | NCT00169247 | Larynx Cancer Hypopharynx Can... | cetuximab Cisplatin Radiotherapy 70... | 18 Years - 75 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma | NCT00169182 | Larynx Cancer Hypopharynx Can... | DOCETAXEL Cisplatin 5-Fluoro-3-Pyri... | 18 Years - 75 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | NCT05337631 | HNSCC Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | 65 Years - | University Hospital Freiburg | ||
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | NCT05798780 | Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | ENHANCE Interve... ENHANCE Interve... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
Adaptive Radiotherapy for Head and Neck Cancer | NCT03096808 | Head and Neck C... Paranasal Sinus... Oropharynx Canc... Oral Cavity Can... Nasopharynx Can... Larynx Cancer Hypopharynx Can... | Adaptive Radiot... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC | NCT00162708 | Oropharynx Canc... Oral Cancer Hypopharynx Can... Larynx Cancer | Radiotherapy 62... Radiotherapy 62... CDDP, 5 Fu | 40 Years - 75 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | NCT00080028 | Head and Neck C... Oropharynx Canc... Larynx Cancer Hypopharynx Can... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients | NCT03039465 | Laryngeal Cance... Hypopharynx Can... | Modified Trans-... | - | HealthCare Global Enterprise Ltd. | |
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03082534 | HNSCC Lip SCC Oral Cavity Can... Oropharynx Canc... Larynx Cancer Hypopharynx Can... Nasopharynx Can... Sinonasal Carci... Cutaneous Squam... Head and Neck N... Head and Neck C... Head and Neck S... | Pembrolizumab, ... | 18 Years - | University of California, San Diego | |
Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma | NCT04995120 | Laryngeal Cance... Hypopharynx Can... Laryngeal Neopl... | chemotherapy TP... | 18 Years - 75 Years | Fudan University | |
Immunological Function After Radiation With Either Proton or Photon Therapy | NCT06016699 | HNSCC Head and Neck C... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | blood draws | 18 Years - | University Medical Center Groningen | |
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
A Pilot Study of Acupuncture Treatment for Dysphagia | NCT00797732 | Carcinomas, Squ... Dysphagia | Acupuncture | 18 Years - | Dana-Farber Cancer Institute | |
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC | NCT00158652 | Oral Cancer Oropharynx Canc... Hypopharynx Can... Larynx Cancer | Conventional ra... middle accelera... very accelerate... 5FU, Paraplatin | 20 Years - 75 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | NCT05798780 | Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | ENHANCE Interve... ENHANCE Interve... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer | NCT01066741 | Oropharynx Canc... Hypopharynx Can... | Homeodent® 1.4% Sodium Bic... | 18 Years - 85 Years | Centre Leon Berard | |
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark |